McNeill, Daniel R <br/><br/>
A dominant-negative form of the major human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents.  [electronic resource] 

 -  Molecular cancer research : MCR  Jan 2007 
 - 61-70 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Intramural 
<br/><br/><label>ISSN: </label>1541-7786 
<br/><br/><label>Standard No.: </label>10.1158/1541-7786.MCR-06-0329  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Amino Acid Substitution<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Binding Sites<br/>CHO Cells<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cells, Cultured<br/>Cricetinae<br/>Cricetulus<br/>DNA--genetics<br/>DNA Damage--drug effects<br/>DNA Repair--drug effects<br/>DNA, Neoplasm--drug effects<br/>DNA-(Apurinic or Apyrimidinic Site) Lyase--genetics<br/>Genes, Dominant<br/>Humans<br/>Hydrogen Peroxide--pharmacology<br/>Lung Neoplasms--drug therapy<br/>Methyl Methanesulfonate--pharmacology<br/>Oxidants--pharmacology